MedAvail Holdings, Inc. Common Stock
MDVL
MDVL was delisted on the 12th of February, 2024.
13 hedge funds and large institutions have $735K invested in MedAvail Holdings, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
30% more funds holding
Funds holding: 10 → 13 (+3)
7% less capital invested
Capital invested by funds: $787K → $735K (-$51.6K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$51.9K |
| 2 |
CCM
Condor Capital Management
Martinsville,
New Jersey
|
+$23.8K |
| 3 |
VF
Virtu Financial
New York
|
+$17K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$3.4K |
| 5 |
RMAM
Raab & Moskowitz Asset Management
Chatham,
New Jersey
|
+$2.55K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$5.11K |
MDVL Hedge Fund Activity: Q4 2019 in Review
13 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in MedAvail Holdings, Inc. Common Stock (MDVL) for Q4 2019, worth a combined $735K — down 6.6% from $787K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new MDVL positions and 0 closed out — a net gain of 3 holders — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $51.9K. The largest seller was Morgan Stanley, cutting an estimated $5.11K.
- 13 institutional investors held MedAvail Holdings, Inc. Common Stock (MDVL) as of Q4 2019, up from 10 in Q3 2019.
- Funds reported $735K of MedAvail Holdings, Inc. Common Stock stock for Q4 2019, down 6.6% quarter-over-quarter.
- 3 funds opened new MedAvail Holdings, Inc. Common Stock positions in Q4 2019 and 0 closed out, a net change of +3 holders.
- The largest MedAvail Holdings, Inc. Common Stock buyer in Q4 2019 was Citadel Advisors, an estimated $51.9K added.
- The largest MedAvail Holdings, Inc. Common Stock seller in Q4 2019 was Morgan Stanley, an estimated $5.11K sold.
Based on aggregated 13F filings for Q4 2019.